Top compounds associated with response to CLDN14


Feature Type Standardized
Nominal ANOVA
mRNA IC-87114 CTRPv2 pan-cancer AAC 0.25 9e-12
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 3e-07
mRNA decitabine CTRPv2 pan-cancer AAC -0.12 4e-06
mRNA barasertib CTRPv2 pan-cancer AAC -0.15 5e-06
mRNA TG-101348 GDSC1000 pan-cancer AAC -0.13 7e-06
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC 0.3 1e-05
mRNA RG-108 CTRPv2 pan-cancer AAC -0.15 6e-05
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 8e-05
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.14 9e-05
Download CSV